comparemela.com
4
5
6
7
8
9
10
Latest Breaking News On - Mike kratky - Page 3 : comparemela.com
Kymera Therapeutics, Inc. (NASDAQ:KYMR) Q4 2022 Earnings Call Transcript
Operator: Hello, and welcome to the Kymera Therapeutics Fourth Quarter 2022 Earnings Conference Call. Please note, this event is being recorded.
United-states
America
Kalpit-patel
Mike-kratky
Andrew-fleszar
Paul-jeng
Raymond-james
Rebecca-mosher
Derek-archila
Bruce-jacobs
Vikram-purohit
Zhi-shu
Pliant shares jump on new data for lung disease drug
BioPharma
Mike-kratky
Boehringer-ingelheim-ofev
Roche-esbriet
Brian-abrahams
Alex-thompson
Pliant-therapeutics
Boehringer-ingelheim
Clinical-trials
Madrigal Pharmaceuticals Gets Price Target Bumps By Analysts Following Successful NASH Study
Madrigal Pharmaceuticals Inc (NASDAQ:MDGL) announced positive topline results from the pivotal Phase 3 MAESTRO-NASH biopsy trial of resmetirom. M.
Jay-olson
Ed-arce
Mike-kratky
Jonathan-wolleben
Goldman-sachs
Madrigal-pharmaceuticals
Madrigal-pharmaceuticals-inc
Hc-wainwright-co
Andrea-tan
MannKind Corporation (MNKD) Q3 2022 Earnings Call Transcript
MNKD earnings call for the period ending September 30, 2022.
Japan
India
Mike-kratky
Gregory-renza
Steven-binder
Michael-castagna
Brandon-folkes-cantor-fitzgerald
Robert-hazlett
Steven-lichtman
Robert-hazlett
Thomas-smith
Brandon-folkes
CymaBay Therapeutics Inc. (CBAY) Q1 2022 Earnings Call Transcript
CBAY earnings call for the period ending March 31, 2022.
Florida
United-states
Japan
China
San-diego
California
Russia
Toronto
Ontario
Canada
Ukraine
America
vimarsana © 2020. All Rights Reserved.